(2S,3S)-2,3-BIS((4-METHYLBENZOYL)OXY)BUTANEDIOIC ACID, ETHYL ACETATE AND METHYL (4S)-8-FLUORO-3,4-DIHYDRO-2-(4-(3-METHOXYPHENYL)-1-PIPERAZINYL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4-QUINAZOLINEACETATE (1:1:1)
UNII BBN35P2CJ3

Substance Identification & Data

This profile provides standardized clinical and technical data for (2s,3s)-2,3-bis((4-methylbenzoyl)oxy)butanedioic Acid, Ethyl Acetate And Methyl (4s)-8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4-quinazolineacetate (1:1:1), uniquely identified by the FDA Unique Ingredient Identifier (UNII) BBN35P2CJ3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2244994-24-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
BBN35P2CJ3
CAS Registry Number
2244994-24-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
(2S,3S)-2,3-BIS((4-METHYLBENZOYL)OXY)BUTANEDIOIC ACID, ETHYL ACETATE AND METHYL (4S)-8-FLUORO-3,4-DIHYDRO-2-(4-(3-METHOXYPHENYL)-1-PIPERAZINYL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4-QUINAZOLINEACETATE (1:1:1)
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C30H30F4N4O4.C20H18O8.C4H8O2
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
CTUAAPGOFXTEJK-KPXZVEDASA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
CCOC(C)=O.Cc1ccc(cc1)C(=O)O[C@@H]([C@H](OC(=O)c2ccc(C)cc2)C(O)=O)C(O)=O.COC(=O)C[C@@H]1N(C(=Nc2c(F)cccc12)N3CCN(CC3)c4cc(OC)ccc4)c5c(OC)ccc(c5)C(F)(F)F

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for (2s,3s)-2,3-bis((4-methylbenzoyl)oxy)butanedioic Acid, Ethyl Acetate And Methyl (4s)-8-fluoro-3,4-dihydro-2-(4-(3-methoxyphenyl)-1-piperazinyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)-4-quinazolineacetate (1:1:1). Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

(2S,3S)-2,3-BIS((4-METHYLBENZOYL)OXY)BUTANEDIOIC ACID, ETHYL ACETATE AND METHYL (4S)-8-FLUORO-3,4-DIHYDRO-2-(4-(3-METHOXYPHENYL)-1-PIPERAZINYL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4-QUINAZOLINEACETATE (1:1:1)
(2S,3S)-2,3-BIS((4-METHYLBENZOYL)OXY)SUCCINIC ACID; ETHYL ACETATE; METHYL (S)-2-(8-FLUORO-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-2-(4-(3-METHOXYPHENYL)PIPERAZIN-1-YL)-3,4-DIHYDROQUINAZOLIN-4-YL)ACETATE (1:1:1)
BUTANEDIOIC ACID, 2,3-BIS((4-METHYLBENZOYL)OXY)-, (2S,3S)-, COMPD. WITH ETHYL ACETATE AND METHYL 8-FLUORO-3,4-DIHYDRO-2-(4-(3-METHOXYPHENYL)-1-PIPERAZINYL)-3-(2-METHOXY-5-(TRIFLUOROMETHYL)PHENYL)-4-QUINAZOLINEACETATE (1:1:1)